Among 200 dialysis patients, 37% were non-compliant with their phosphate binders compared with 12% to 18% of patients who ...

Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Hydration is another critical factor in managing CKD. Encouraging water intake through the use of hydration-friendly diets, water fountains, and owner-administered subcutaneous fluid therapy can help ...

When people think of kidney disease, they usually think about problems with how the body removes waste—not about skin issues.

Cats are notorious for being tough. They simply refuse to show they are in pain. It’s a huge problem because owners don’t ...

Aviceda Therapeutics has got biotech financing in 2025 off to a flying start by raising $207.5 million to take its lead drug for sight-robbing disease ... iron-based phosphate binder AP301 ...

The San Carlos, California-based biotech is now looking to use its series C cash to fund a phase 2b study to further demonstrate the efficacy of its mannose-1-phosphate replacement therapy GLM101.

At close: April 17 at 4:00:01 PM EDT ...

The authors developed a methodology to graph antigenic surface loops on influenza virus neuraminidases. The hybrid proteins retained the structure of the neuraminidase scaffold and the antigenicity of ...